Clinical Trial Update: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating androgen deprivation therapy in patients with advanced salivary gland cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Salivary Gland Cancer | Phase 2 | Status: COMPLETED